Caffeine and the Developing Brain

Molecular and Cellular Effects

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Otherpeer-review

Abstract

Caffeine is a widely used, legal psychoactive drug, commonly ingested during pregnancy in tea, coffee, cola, and energy drinks. Caffeine concentrations in the fetus are similar to maternal levels as caffeine readily crosses the placenta. This chapter reviews data indicating that fetal caffeine exposure during pregnancy can potentially affect brain development, predominantly through its ability to antagonize adenosine receptors. Most of the available data are derived from animal experimentation and there are little data concerning the neurodevelopmental effects of caffeine in humans. The findings of experimental studies are often conflicting due to differences in species, the degree of caffeine exposure, developmental stage of the brain at exposure, age at assessment, and the brain region investigated. However, there is now sufficient evidence to suggest that caffeine use during pregnancy, especially prolonged, high levels of exposure, can alter fetal brain development and may contribute to adverse long-term neurodevelopmental outcomes.

Original languageEnglish
Title of host publicationGeneral Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug Addictions
PublisherAcademic Press
Chapter75
Pages753-761
Number of pages9
Volume3
ISBN (Electronic)9780128006771
ISBN (Print)9780128006344
DOIs
Publication statusPublished - 13 May 2016

Keywords

  • Caffeine
  • Development
  • Fetus
  • Neurodevelopment
  • Pregnancy

Cite this

Atik, A., Harding, R., De Matteo, R., & Tolcos, M. (2016). Caffeine and the Developing Brain: Molecular and Cellular Effects. In General Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug Addictions (Vol. 3, pp. 753-761). Academic Press. https://doi.org/10.1016/B978-0-12-800634-4.00075-5
Atik, Anzari ; Harding, Richard ; De Matteo, Robert ; Tolcos, Mary. / Caffeine and the Developing Brain : Molecular and Cellular Effects. General Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug Addictions. Vol. 3 Academic Press, 2016. pp. 753-761
@inbook{f595f09de7ff46019fde459eaeab2890,
title = "Caffeine and the Developing Brain: Molecular and Cellular Effects",
abstract = "Caffeine is a widely used, legal psychoactive drug, commonly ingested during pregnancy in tea, coffee, cola, and energy drinks. Caffeine concentrations in the fetus are similar to maternal levels as caffeine readily crosses the placenta. This chapter reviews data indicating that fetal caffeine exposure during pregnancy can potentially affect brain development, predominantly through its ability to antagonize adenosine receptors. Most of the available data are derived from animal experimentation and there are little data concerning the neurodevelopmental effects of caffeine in humans. The findings of experimental studies are often conflicting due to differences in species, the degree of caffeine exposure, developmental stage of the brain at exposure, age at assessment, and the brain region investigated. However, there is now sufficient evidence to suggest that caffeine use during pregnancy, especially prolonged, high levels of exposure, can alter fetal brain development and may contribute to adverse long-term neurodevelopmental outcomes.",
keywords = "Caffeine, Development, Fetus, Neurodevelopment, Pregnancy",
author = "Anzari Atik and Richard Harding and {De Matteo}, Robert and Mary Tolcos",
year = "2016",
month = "5",
day = "13",
doi = "10.1016/B978-0-12-800634-4.00075-5",
language = "English",
isbn = "9780128006344",
volume = "3",
pages = "753--761",
booktitle = "General Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug Addictions",
publisher = "Academic Press",
address = "United States of America",

}

Atik, A, Harding, R, De Matteo, R & Tolcos, M 2016, Caffeine and the Developing Brain: Molecular and Cellular Effects. in General Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug Addictions. vol. 3, Academic Press, pp. 753-761. https://doi.org/10.1016/B978-0-12-800634-4.00075-5

Caffeine and the Developing Brain : Molecular and Cellular Effects. / Atik, Anzari; Harding, Richard; De Matteo, Robert; Tolcos, Mary.

General Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug Addictions. Vol. 3 Academic Press, 2016. p. 753-761.

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Otherpeer-review

TY - CHAP

T1 - Caffeine and the Developing Brain

T2 - Molecular and Cellular Effects

AU - Atik, Anzari

AU - Harding, Richard

AU - De Matteo, Robert

AU - Tolcos, Mary

PY - 2016/5/13

Y1 - 2016/5/13

N2 - Caffeine is a widely used, legal psychoactive drug, commonly ingested during pregnancy in tea, coffee, cola, and energy drinks. Caffeine concentrations in the fetus are similar to maternal levels as caffeine readily crosses the placenta. This chapter reviews data indicating that fetal caffeine exposure during pregnancy can potentially affect brain development, predominantly through its ability to antagonize adenosine receptors. Most of the available data are derived from animal experimentation and there are little data concerning the neurodevelopmental effects of caffeine in humans. The findings of experimental studies are often conflicting due to differences in species, the degree of caffeine exposure, developmental stage of the brain at exposure, age at assessment, and the brain region investigated. However, there is now sufficient evidence to suggest that caffeine use during pregnancy, especially prolonged, high levels of exposure, can alter fetal brain development and may contribute to adverse long-term neurodevelopmental outcomes.

AB - Caffeine is a widely used, legal psychoactive drug, commonly ingested during pregnancy in tea, coffee, cola, and energy drinks. Caffeine concentrations in the fetus are similar to maternal levels as caffeine readily crosses the placenta. This chapter reviews data indicating that fetal caffeine exposure during pregnancy can potentially affect brain development, predominantly through its ability to antagonize adenosine receptors. Most of the available data are derived from animal experimentation and there are little data concerning the neurodevelopmental effects of caffeine in humans. The findings of experimental studies are often conflicting due to differences in species, the degree of caffeine exposure, developmental stage of the brain at exposure, age at assessment, and the brain region investigated. However, there is now sufficient evidence to suggest that caffeine use during pregnancy, especially prolonged, high levels of exposure, can alter fetal brain development and may contribute to adverse long-term neurodevelopmental outcomes.

KW - Caffeine

KW - Development

KW - Fetus

KW - Neurodevelopment

KW - Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=84978338366&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-800634-4.00075-5

DO - 10.1016/B978-0-12-800634-4.00075-5

M3 - Chapter (Book)

SN - 9780128006344

VL - 3

SP - 753

EP - 761

BT - General Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug Addictions

PB - Academic Press

ER -

Atik A, Harding R, De Matteo R, Tolcos M. Caffeine and the Developing Brain: Molecular and Cellular Effects. In General Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug Addictions. Vol. 3. Academic Press. 2016. p. 753-761 https://doi.org/10.1016/B978-0-12-800634-4.00075-5